Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Kintara Therapeutics Inc. buy melinda

Start price
€1.21
29.09.20 / 50%
Target price
€1.80
04.11.21
Performance (%)
-18.78%
End price
€0.99
13.10.21
Summary
This prediction ended on 13.10.21 with a price of €0.99. The prediction for Kintara Therapeutics Inc. disappointed with a performance of -18.78%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Kintara Therapeutics Inc. - - - -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to melinda what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Delmar Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -18.78%
Target price 1.800
Change
Ends at 04.11.21

Buy mit Kursziel 1,8

In the thread Trading Delmar Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -18.78%
Target price 1.800
Change
Ends at 04.11.21

Buy beendet

Stopped prediction by melinda for Kintara Therapeutics Inc.

buy
Kintara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.081
09.04.23
€0.15
-
02.05.23

Could be worthwhile Investment >10% per year
buy
Kintara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.99
13.10.21
€1.50
13.10.22
-23.86%
24.10.21

Could be worthwhile Investment >10% per year